Forex
World
Market
Business
Cryptocurrency
Commodities
MAP
Publish for free
Business
financetom
/
Business
/
--First Financial Keeps Quarterly Dividend at $0.51 a Share, Payable July 15 to Shareholders of Record July 1
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
Forex
Stocks Market
Commodities
--First Financial Keeps Quarterly Dividend at $0.51 a Share, Payable July 15 to Shareholders of Record July 1
Jun 18, 2025 11:27 AM
02:07 PM EDT, 06/18/2025 (MT Newswires) --
Price: 50.96, Change: +0.20, Percent Change: +0.39
Previous page:
--TFS Financial Maintains Dividend at $0.2825 per Share, Payable on June 25 to Shareholders of Record on June 11
Next page:
American International Group Prices Secondary Offering of Corebridge Financial Targeting $876 Million in Gross Proceeds
Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Release time ⇩
Release time ⇧
Like count ⇩
Show More Comments
Related Articles >
--TFS Financial Maintains Dividend at $0.2825 per Share, Payable on June 25 to Shareholders of Record on June 11
May 31, 2024
04:58 AM EDT, 05/31/2024 (MT Newswires) -- Price: 12.78, Change: -0.31, Percent Change: -2.37 ...
American International Group Prices Secondary Offering of Corebridge Financial Targeting $876 Million in Gross Proceeds
May 31, 2024
04:49 AM EDT, 05/31/2024 (MT Newswires) -- American International Group ( AIG ) said Thursday it priced a secondary offering of Corebridge Financial ( CRBG ) common shares at $29.20 per share. As the selling stockholder, American International has offered 30 million common shares out of about 608 million shares outstanding of Corebridge Financial ( CRBG ), targeting gross proceeds...
Regeneron Pharmaceuticals, Sanofi Say Dupixent FDA Application Decision Delayed by 3 Months
May 31, 2024
04:49 AM EDT, 05/31/2024 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) and Sanofi ( SNY ) said Friday the US Food and Drug Administration has extended until Sept. 27 the action date on the biologics license application for Dupixent as a supplemental maintenance treatment in adults with uncontrolled chronic obstructive pulmonary disease. The three-month extension comes after the FDA...
Prelude Therapeutics Files for $400 Million Mixed Shelf
May 31, 2024
04:54 AM EDT, 05/31/2024 (MT Newswires) -- Prelude Therapeutics ( PRLD ) filed Thursday a registration statement covering the potential sale of up to $400 million of securities from time to time. The securities include common stock, preferred stock, debt securities, warrants, subscription rights and units. Unless otherwise provided in a prospectus supplement, the company said it expects to use...
About
Terms and Conditions
Privacy policy
Cookie Settings
Contact Us
Services
Login
register
financetom
Market
Personal Finance
Business
Economy
Cryptocurrency
MAP
Links
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
Copyright 2023-2026 -
www.financetom.com
All Rights Reserved
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
MAP